Title Collection Author Date
Stocks to Benefit From Pandemic Pet Boom Stock Insight Vikram Barhat 21-07-21
Globalization Declining? Not in Investor Portfolios Market Insights Dan Lefkovitz 18-06-21
3 Stocks to Ride the Travel Rebound Stock Insight Vikram Barhat 16-06-21
No Vaccine IP? No Problem! Stock Insight Karen Andersen, CFA 09-05-21
Tackling Vaccine Hesitancy: Knowledge vs Fear Special Report Scott Mackenzie 15-04-21
Hotels Set for Full Rebound Stock Insight Andrew Willis 01-04-21
Coronavirus Market Crash Was the Shortest Market Insights Paul D. Kaplan 15-03-21
Covid-19, Women and Investing Market Insights Sustainalytics 10-03-21
Ask the Experts: RRSP Investments Personal Finance Ruth Saldanha 25-02-21
Ask the Experts: RRSPs in COVID Personal Finance Andrew Willis 23-02-21
Should You Invest in the Vaccine Makers? Market Insights Morningstar 22-01-21
Vaccine Rollout, Herd Immunity to End Pandemic Market Insights Karen Andersen, CFA 12-01-21
2020 Lessons from FinTwit Influencers Personal Finance Larissa Fernand 22-12-20
COVID-19 Will Stress Berkshire Stock Insight Greggory Warren, CFA 18-12-20
The 10 Biggest IPOs of 2020 Stock Insight Andrew Willis 16-12-20
What History Can Teach Us About the Post-COVID Economy Market Insights Preston Caldwell 24-11-20
Financial Planning in a Post-COVID-19 World Market Insights Ruth Saldanha 14-11-20
Pfizer Leads Vaccine Race Stock Insight Damien Conover, CFA 09-11-20
3 Stocks to Sanitize Your Portfolio Stock Insight Vikram Barhat 28-10-20
COVID-19 and the Future of Financial Planning Personal Finance Christine Benz 13-10-20
History’s Lessons for the Post-Pandemic World Market Insights Preston Caldwell 22-09-20
Stock Analyst Sentiment in COVID-19 Market Insights Ian Tam, CFA 28-08-20
COVID: Which Markets Have Recovered? Market Insights Annalisa Esposito 27-08-20
A Tale of Two Markets Market Insights Ian Tam, CFA 25-08-20
We Don't Expect a Repeat of 2008 Market Insights Eric Compton 30-07-20
What a Covid-19 Vaccine Means for Investors Market Insights Karen Andersen, CFA 22-07-20
Chinese Tech Stocks Bouncing Back from Pandemic Lows Stock Insight Vikram Barhat 15-07-20
3 Stocks Susceptible to H-1B Visa Clampdown Stock Insight Vikram Barhat 08-07-20
Telecom Stocks Showing Resilience Both Sides of the Border Stock Insight Vikram Barhat 03-06-20
Will COVID-19 send us back to lockdown? Special Report Ruth Saldanha 22-05-20
Four healthcare stocks racing to develop a cure Stock Insight Vikram Barhat 13-05-20
Canadian real estate remains resilient Market Insights Ruth Saldanha 12-05-20
Low carbon, high performance Market Insights Ian Tam, CFA 12-05-20
Is Remdesivir-maker Gilead Sciences a 'buy'? Stock Insight Karen Andersen, CFA 11-05-20
Canada’s dividend aristocrats fall from grace Stock Insight Andrew Willis 07-05-20
The hardest decision in investing Personal Finance Ruth Saldanha 06-05-20
Here come the robots Stock Insight Andrew Willis 05-05-20
What the pandemic means for Berkshire Hathaway Stock Insight Susan Dziubinski 01-05-20
Near-term approval of Gilead's Remdesivir likely Stock Insight Karen Andersen, CFA 29-04-20
Top social distancing stocks Stock Insight Vikram Barhat 29-04-20
Focus on the survivors Manager Insight Diana Cawfield 23-04-20
The tech fund that barely fell Fund Insight Andrew Willis 17-04-20
Is it time to keep your distance from Zoom? Stock Insight Lex Hall 17-04-20
After China, where next? Stock Insight Vikram Barhat 14-04-20
How have ETFs fared during this bear market? ETF Insight Christine Benz 13-04-20
Volatility is here to stay Market Insights Ruth Saldanha 13-04-20
Miners make hay while gold shines Stock Insight Vikram Barhat 08-04-20
Will Shopify lead the way? Stock Insight Andrew Willis 03-04-20
Is this 2008 all over again? Market Insights Eric Jacobson 31-03-20
COVID-19: Will Canadian house prices fall? Market Insights Ruth Saldanha 31-03-20
Page   1 of 2
© Copyright 2021 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Cookies